The INFUSE-Morphine IIB Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneous Morphine in Healthy Volunteers-Reference-Cited by-同舟云学术

The INFUSE-Morphine IIB Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneous Morphine in Healthy Volunteers

Published:2009-11 Issue:5 Volume:38 Page:673-682
ISSN:0885-3924
Container-title:Journal of Pain and Symptom Management
language:en
Short-container-title:Journal of Pain and Symptom Management

Author:

Thomas Jay R.,Yocum Richard C.,Haller Michael F.,Flament Jocelyne

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,General Nursing

Reference20 articles.

1. Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer;Bruera;J Pain Symptom Manage,1990

2. Utility of clysis for hydration in nursing home residents;Hussain;J Am Geriatr Soc,1996

3. Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration;Frost;Expert Opin Drug Deliv,2007

4. Intravenous versus subcutaneous morphine titration in patients with persisting exacerbation of cancer pain;Elsner;J Palliat Med,2005

5. Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration;Koshy;J Pain Palliat Care Pharmacother,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency;Journal of Controlled Release;2023-01

2. Hyaluronidases and hyaluronate lyases: From humans to bacteriophages;Colloids and Surfaces B: Biointerfaces;2021-12

3. Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery;Expert Opinion on Drug Delivery;2021-09-29

4. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling;Journal of Pharmacokinetics and Pharmacodynamics;2020-06-04

5. ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20;Drug Delivery;2019-01-01